 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > TRC > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：C596480 |
| 產(chǎn)品名稱：(αS)-2-Chloro-α-(1-methoxy-1-methylethoxy)-benzeneacetic Acid Methyl E |
| 產(chǎn)品CAS：552843-48-8 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
C596480 |
| 名稱: |
(αS)-2-Chloro-α-(1-methoxy-1-methylethoxy)-benzeneacetic Acid Methyl Ester |
| 別名: |
(S)-Methyl 2-(2-chlorophenyl)-2-((2-methoxypropan-2-yl)oxy)acetate |
| CAS號(hào): |
552843-48-8 |
| 分子式: |
C??H??ClO? |
| 分子量: |
272.72 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
(αS)-2-Chloro-α-(1-methoxy-1-methylethoxy)-benzeneacetic Acid Methyl Ester is an intermediate in the synthesis of (S)-Carisbamate (C183510). Carisbamate is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
